Boiron SA (0DTF.L)

EUR 27.0

(-0.37%)

Total Assets Summary of Boiron SA

  • Boiron SA's latest annual total assets in 2023 was 590.2 Million EUR , down -25.24% from previous year.
  • Boiron SA's latest quarterly total assets in 2024 Q2 was 557.65 Million EUR , down 0.0% from previous quarter.
  • Boiron SA reported annual total assets of 789.49 Million EUR in 2022, up 2.44% from previous year.
  • Boiron SA reported annual total assets of 770.7 Million EUR in 2021, down -1.42% from previous year.
  • Boiron SA reported quarterly total assets of 752.77 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • Boiron SA reported quarterly total assets of 590.2 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of Boiron SA (2023 - 2001)

Historical Annual Total Assets of Boiron SA (2023 - 2001)

Year Total Assets Total Assets Growth
2023 590.2 Million EUR -25.24%
2022 789.49 Million EUR 2.44%
2021 770.7 Million EUR -1.42%
2020 781.82 Million EUR 2.29%
2019 764.28 Million EUR -0.36%
2018 767.07 Million EUR -4.16%
2017 800.4 Million EUR 6.01%
2016 755.03 Million EUR 8.57%
2015 695.44 Million EUR 3.87%
2014 669.55 Million EUR 0.29%
2013 667.58 Million EUR 15.24%
2012 579.28 Million EUR -1.42%
2011 587.6 Million EUR 5.24%
2010 558.33 Million EUR 6.98%
2009 521.93 Million EUR 12.65%
2008 463.34 Million EUR 8.16%
2007 428.39 Million EUR 3.96%
2006 412.05 Million EUR -3.56%
2005 427.25 Million EUR 57.65%
2004 271.01 Million EUR 9.29%
2003 247.97 Million EUR 7.47%
2002 230.72 Million EUR 12.08%
2001 205.86 Million EUR 0.0%

Peer Total Assets Comparison of Boiron SA

Name Total Assets Total Assets Difference
Laboratorios Farmaceuticos Rovi, S.A. 799.88 Million EUR 26.214%
Vetoquinol SA 692.23 Million EUR 14.739%
Valneva SE 469.39 Million EUR -25.738%
AB Science S.A. 25.49 Million EUR -2214.604%
Nanobiotix S.A. 93.89 Million EUR -528.562%
PHAXIAM Therapeutics S.A. 51.3 Million EUR -1050.332%
Vivoryon Therapeutics N.V. 30.82 Million EUR -1814.434%
BioSenic S.A. 9.55 Million EUR -6074.296%
ABIVAX Société Anonyme 327.06 Million EUR -80.455%
Formycon AG 890.36 Million EUR 33.712%